THB places first risk with GHRF facility for COVID-19 vaccine
18-01-2021
Lloyd's Lab launches COVID-19 cohort with three new insurtechs
06-07-2020
Lloyd's COVID-19 losses of £2.5bn to £3.5bn 'entirely manageable': report
02-07-2020
Shutterstock/by-bote
Lloyd's of London has granted in principle approval to new specialised 'syndicate in a box', Syndicate 1796, set up to insure the storage and transportation of a COVID-19 vaccine once developed to emerging economies.
The rest of this article is locked. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, and all the other content. Please use this link and follow the steps.
To take out a free two week trial, use the same link but select the 'trial' option in the dropdown box.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Elliot at efield@newtonmedia.co.uk
Lloyd’s of London, Parsyl, AXAL XL, McGill, Partners and Gavi, the Vaccine Alliance, Syndicate 1796, Insurance, Reinsurance, John Neal, London market, UK
